Search

Issue
Title
Authors
Incidence and associated factors for incidental prostate cancer following endoscopic enucleation for benign prostate hyperplasia performed by a single urologist
Sorokin N.I., Strigunov A.A., Nesterova O.Y., Pshikhachev A.M., Burlakov I.D., Oleynikova N.A., Varentsov M.G., Bondar I.V., Tereshina A.D., Veriaskina A.E., Kamalov A.A.
Correlation of storage symptoms or overactive bladder symptoms post transurethral resection of the prostate with the duration of catheter use in a patient with urinary retention due to benign prostate hyperplasia
Perdinan A., Alvarino A., Ilmiawati C., Myh E.
The study Peptide-ALPHA: a role of bladder regulatory peptides and alpha-blockers in combination therapy for LUTS
Spivak L.G., Morozov A.O., Bogatova S.R.
Efficacy and safety of minimally invasive injection steam therapy for lower urinary tract symptoms caused by benign prostate hyperplasia (first clinical experience in the Russian Federation)
Shibaev A.N., Podoynitsyn A.A., Suleymanov R.S., Pavlova Y.V., Bogatov D.V., Federyakin D.V., Ivkin E.V., Kozlova A.T., Kolontarev K.B., Govorov A.V., Pushkar D.Y.
Possibilities of using Urorek® (silodosin, 8 mg) for empirical therapy in patients with lower urinary tract symptoms due to benign prostatic hyperplasia: results of the Russian multicenter observational study MERCURY
Pushkar D.Y., Bernikov A.N., Shvedov A.M., Zyryanov A.V., Feofilov I.V., Igoshkin A.V., Medvedev V.L., Efremov M.E., Komyakov B.K., Fadeev V.A.
Clinical and laboratory features of bladder explosion: a rare complication of transurethral prostatic procedures
Zubkov I.V., Sevryukov F.A., Goloviznin Y.V., Korotaev P.N., Ovsyukov A.A., Kozvonin V.A., Burkov A.A., Semenychev D.V.
Analysis of satisfaction with drug therapy for benign prostatic hyperplasia in elderly and senile patients
Popov S.V., Huseynov R.H., Sivak K.V., Pomeshkin E.V., Sengirbaev D.I., Perepelitsa V.V., Bunenkov N.V., Lelyavina T.A.
Use of a combined form of prostate extract and alpha-adrenoblocker in patients after transurethral resection of the prostate
Pavlov V.N., Kazikhinurov A.A., Sabirzyanov S.S., Kazikhinurov R.A., Karaguzin R.A.
Is the rate of complications in simultaneous inguinal hernia repair and extraperitoneal simple prostatectomy using laparoscopic approach increased compared to simple prostatectomy alone?
Biktimirov R.G., Martov A.G., Biktimirov T.R., Kaputovskij A.A.
The questionnaire of integrated assessment of male sexuality is a tool for analyzing a man's sexual functions throughout his life
Kogan M.I., Efremov M.E., Medvedev V.L., Anosov A.D., Akhokhov Z.M., Sinyavskaya T.G., Khmaruk I.N.
Efficiency and safety of silodosin for treatment of lower urinary tract symptoms, associated of benign prostatic hyperplasia
Krivoborodov G.G., Tur E.I.
Herpes viruses and human papillomavirus in prostate cancer: first results
Mikhaleva L.M., Kamalov А.А., Karpov V.K., Okhobotov D.A., Akopyan E.P., Shakhpazyan N.K., Shaparov B.M., Nesterova O.Y., Martirosyan L.K., Ekhoyan М.М., Osmanov О.А.
COMBINATION DRUG THERAPY IN PATIENTS WITH BPH
Kuz’menko A.V., Kuz’menko V.V., Gyaurgiev T.A.
QUALITY OF LIFE IN PATIENTS WITH LOWER URINARY TRACT SYMPTOMS AFTER TURP FOR BENIGN PROSTATIC HYPERPLASIA
Pushkar D.Y., Bernikov A.N., Khodyreva L.A., Dudareva A.A., Al'-Shukri S.K., Amdii R.E., Aboyan I.A., Shiranov K.A., Medvedev V.L., Efremov M.E.
Our experience of holmium laser enucleation of the prostate
Kutluev M.M., Safiullin R.I.
Combination of a1-blockers and phosphodiesterase type 5 inhibitor in patients with benign prostatic hyperplasia and erectile dysfunction: results of observatory prospective multicenter study
Borisov V.V.
A COMPARATIVE CHARACTERISTICS OF TREATMENT RESULTS OF PATIENS WITH BENIGN PROSTATIC HYPERPLASIA IN COMBINATION WITH HYPOGONADISM
Kamalov A.A., Vasilevskiy R.P., Okhobotov D.A., Neplokhov E.A.
The effectiveness of the integrated approach to the treatment of chronic prostatitis, including in patients with benign prostatic hyperplasia
Zhiborev A.B., Martov A.G.
Combination therapy for benign prostatic hyperplasia in the light of clinical guidelines
Vinarov A.Z., Spivak L.G., Mironov A.V.
Monopolar transurethral enucleation of benign prostatic hyperplasia. Our initial experience
Tsarichenko D.G., Simberdeev R.R., Glybochko P.V., Alyaev Y.G., Rapoport L.M., Sukhanov R.B., Sorokin N.I., Enikeev D.V., Davydov D.S.
UROFOGICAF ASPECTS OF THE FOX - FORDYCE DISEASE
Dutov V.V., Romanov D.V.
Clinical and urodynamic evaluation of efficacy of conservative treatment of urination disorders in patients with benign prostate. hyperplasia
Danilov V.V., Danilova T.I., Danilov V.V., Danilov V.V.
HIGH-TECHNOLOGY EXTRAURETHRAL ADENOMECTOMY
Sergiyenko N.F., Vasilchenko M.I., Kudryashov O.I., Lototsky M.M., Begayev A.I., Schekochikhin A.V., Shershnev S.P., Reynyuk O.L.
Evaluation of the effect of Alfuprost® MR on detrusor thickness and bladder mass in patients with detrusor hypertrophy caused by benign prostatic hyperplasia
Kuzmenko A.V., Kuzmenko V.V., Gyaurgiev T.A.
RATIONALE OF PHARMACOTHERAPY DURATION IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA (A CLINICAL-MORPHOLOGICAL STUDY)
Sitdykova M.E., Tsyplakov D.E., Sitdykov E.N., Nurtdinov A.R.
Predictors of bladder neck contracture after transurethral procedure on the prostate
Abbosov S.A., Sorokin N.I., Kadrev A.V., Shomarufov A.B., Nesterova O.Y., Akilov F.A., Kamalov A.A.
Lower urinary tract symptoms after transurethral resection of the prostate
Ergakov D.V., Martov A.G., Turin D.E., Andronov A.S.
The current status of surgical treatment of benign prostatic hyperplasia with volume over 80 сс
Biktimirov R.G., Martov A.G., Biktimirov T.R., Kaputovskij A.A.
Patients with newly diagnosed benign prostatic hyperplasia
Meshkov I.O., Kulchavenya E.V., Shevchenko S.Y., Neimark A.I.
Russian experience with Vitaprost Forte suppositories in patients with lower urinary tract symptoms and benign prostatic hyperplasia: comparative analysis of studies
Korneev I.A.
Holmium laser enucleation of the prostate (HOLEP) for small, large and giant prostatic hyperplasia. Practice guidelines. Experience of more than 450 surgeries
Enikeev D.V., Glybochko P.V., Alyaev Y.G., Rapoport L.M., Enikeev M.E., Tsarichenko D.G., Sorokin N.I., Sukhanov R.B., Dimov A.M., Khamraev O.K., Davydov D.S., Taratkin M.S., Simberdeev R.R.
TREATMENT OF AGE-RELATED ANDROGEN DEFICIENCY IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA
Kaprin A.D., Kostin A.A., Vinogradov I.V., Magamadov E.L.
Correction of erectile dysfunction in patients with BPH using daily administration of tadalafil 5 mg against the background of combined drug. therapy
Volkov A.A., Petrichko M.I., Budnik N.V.
ON THE QUESTION OF THE SO-CALLED GOLD STANDARD OF SURGICAL TREATMENT OF BENIGN PROSTATIC HYPERPLASIA
Sergienko N.F., Vasilchenko M.I., Kudryashov O.I., Begayev A.I., Schekochihin A.V., Shershnev S.P., Reynjuk O.L., Lototsky M.M.
Efficiency and safety of the drug adenoprosin in patients with prostate diseases. A systematic review and meta-analysis
Morozov А.О., Timofeeva Е.Y., Suvorov А.Y., Allenov S.N., Spivak L.G.
ANALYSIS OF FACTORS AFFECTING THE COMPLIANCE WITH MEDICAL THERAPY FOR BENIGN PROSTATIC HYPERPLASIA
Malkhasyan V.A., Rasner P.I., Gevorkyan A.R., Semenyakin I.V., Tedeev A.V., Pushkar D.Y.
A case of successful plasma transurethral enucleationof benign prostatic hyperplasia the size of 530 cm3
Sevryukov F.A., Nakagawa K., Kochkin A.D., Volodin M.A., Semenychev D.V.
Experimental study on the efficiency of rectal suppositories with oxidized dextran in patients with benign prostatic hyperplasia
Novikova E.G., Troitsky A.V., Ukah H.U., Selyatitskaya V.G.
Tadalafil 5 mg once daily is a rationale option for simultaneous treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia and erectile 146 dysfunction
Kaputovskij A.A.
A comparison between enucleation of the prostate using holmium and thulium laser in volume over 80 cc: retrospective clinical study with 12-months follow-up
Popov S.V., Orlov I.N., Martov A.G., Malevich S.M., Sushina I.V., Grin E.A., Obidnyak V.M., Dovganskiy D.V., Topuzov T.M.
Prognostic significance of prostate-specific antigen in defining indications for initial prostate biopsy
Popov S.V., Guseinov R.G., Skryabin O.N., Orlov I.N., Martov A.G.
NEW OPPORTUNITIES TO TREAT COMBINED LUTS IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA -PREMISES AND ADVANTAGES
Gadzhieva Z.K., Kazilov Y.B.
Features of diagnosis and treatment of various disorders of urination by physicians of the Republic of Dagestan and other regions of the North Caucasus and Southern Federal districts
Gadzhieva Z.K., Kazilov Y.B., Alyaev Y.G., Aboyan I.A.
RISK FACTORS FOR ANTERIOR URETHRAL STRICTURES AFTER TRANSURETHRAL RESECTION OF BENIGN PROSTATIC HYPERPLASIA
Grechenkov A.S., Glybochko P.V., Alyaev Y.G., Bezrukov E.A., Vinarov A.Z., Butnaru D.V., Sukhanov R.B.
The use of laser vaporization for the treatment of benign prostatic hyperplasia
Ustinov D.V., Kholtobin D.P., Kulchavenya E.V., Aizikovich B.I.
MODIFIED METHOD OF RETROPUBIC PROSTATECTOMY (RMAPE METHOD)
Veliyev E.I., Sokolov A.E., Bogdanov A.B., Ilyushin L.V.
The comparative analysis of surgical procedures a in patients with benign prostatic hyperplasia and type 2 diabetes mellitus
Volkov S.N., Mikheev R.K., Grigoryan O.R., Andreeva E.N.
COMPARATIVE ASSESSMENT OF TREATMENTS FOR PROSTATE ADENOMA GREATER THAN 100 CM3
Orlov I.N., Popov S.V., Martov A.G., Gallyamov E.A., Malevich S.M., Sushina I.V., Grin’ E.A., Sanzharov A.E., Novikov A.B., Sergeev V.P., Kochkin A.D.
EFFEKTIVNOST' PRIMENENIYa PREPARATOV OMNIK I OMNIK OKAS U PATsIENTOV S SIMPTOMAMI NIZhNIKh MOChEVYVODYaShchIKh PUTEY NA FONE DOBROKAChESTVENNOY GIPERPLAZII PROSTATY (MNOGOTsENTROVAYa NABLYuDATEL'NAYa PROGRAMMA)
Shalekenov B.U., Kuandykov Y.A., Shalekenov S.B.
Involvement of p2 receptors in the contractile activity of the bladder in patients with benign prostatic hyperplasia
Ziganshin A.U., Ivanova D.V., Zubkov E.A., Sitdykova M.E.
Economic aspects of treatment for lower urinary tract symptoms associated with benign prostatic hyperplasia
Startsev V.Y., Dudarev V.A., Sevryukov F.A., Zabrodina N.B.
The experience of using drug Afalaza for treatment of lower urinary symptoms in treatment-naive patients with benign prostatic hyperplasia
Kupriyanov Y.A., Rasner P.I., Rokhlikov I.M., Akrikidi A.A., Soloviev V.V., Markov A.A., Nozdrin E.V., Logvinov L.A., Vasilevskiy R.P., Skrupskiy K.S., Pushkar D.Y., Putilovskiy M.A., Epstein O.I.
Comparative study of extraperitoneoscopic adenomectomy and monopolar transurethral resection in surgical management of benign prostatic hyperplasia with prostate volume of 100-180 cm3
Biktimirov R.G., Martov A.G., Biktimirov T.R., Marapov D.I., Kaputovskij A.A.
X-RAY-GUIDED ENDOVASCULAR SURGERY IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA AND PROSTATE CANCER
Neimark A.I., Tachalov M.A., Neimark B.A., Torbik D.V., Arzamastsev D.D.
An improved method of risk prediction and prevention of esophagogastroduodenal bleeding in geriatric urology
Leshhenko I.G., Dodonova N.A., Sidash B.V., Shatohina I.V., Nizhegorodcev A.S., Lazarev I.J., Krechko N.A.
LONG-TERM OUTCOMES OF THE USE OF A-BLOCKERS TAMSULOSIN IN MEN WITH LOWER URINARY TRACT SYMPTOMS AND BENIGN PROSTATIC HYPERPLASIA
Krivoborodov G.G., Tur E.I.
Experience of the use of silodosin in acute urinary retention caused by benign prostatic hyperplasia
Neymark A.I., Nozdrachyov N.A.
POSTCOVID COMPLICATIONS IN UROLOGY. PREVENTION
Kuzmenko A.V., Kuzmenko V.V., Gyaurgiev T.A.
The results of the multicenter prospective comparative study of Fndrogel in men with endogenous testosterone deficiency and lower urinary tract symptoms, associated with benign prostate hyperplasia («Potok»)
Kogan M.I., Avadieva N.E., Gevorkyan L.S., Loginov Y.A., Metelkin A.M., Mitin A.A., Patrikeev A.A.
THE ROLE OF EXTRAPERITONEOSCOPIC ADENOMECTOMY IN THE MANAGEMENT OF BENIGN PROSTATIC HYPERPLASIA GREATER THAN 80 CM3
Biktimirov R.G., Martov A.G., Biktimirov T.R., Kaputovskii A.A.
ULTRASOUND INDICATORS OF THE PROSTATE, URINARY BLADDER AND UROFLOWMETRY PARAMETERS IN THE DIAGNOSIS OF INFRAVESICAL OBSTRUCTION IN MEN WITH BENIGN PROSTATIC HYPERPLASIA
Krivoborodov G.G., Efremov N.S., Bolotov A.D.
The use of bioregulatory peptides in the treatment of men with benign prostatic hyperplasia and chronic prostatitis
Kuzmenko A.V., Vinnik Y.Y., Kuzmenko V.V., Gyaurgiev T.A.
A novel method for non-invasive mechanical ablation of prostate tumors using pulsed focused ultrasound
Khokhlova V.A., Rosnitskiy P.B., Tsysar S.A., Buravkov S.V., Sapozhnikov O.A., Karzova M.M., Khokhlova T.D., Maxwell A.D., Gaifullin N.M., Kadrev A.V., Okhobotov D.A., Kamalov A.A., Schade G.R.
Prediction of the effectiveness of the therapy of LUTS/BPH by Serenoa repens extracts
Sivkov A.V., Golovanov S.A., Zhukova L.V.
Current concept of diagnosis of benign prostatic hyperplasia
Vinnik Y.Y., Andreichikov A.V., Klimov N.Y.
PREVENTION OF THROMBOHEMORRHAGIC POSTOPERATIVE COMPLICATIONS IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA
Atamanova E.A., Andryukhin M.I., Vasilenko I.A., Makarov O.V.
FEATURES OF CLINICAL COURSE AND MORPHOMETRIC PARAMETERS OF BENIGN PROSTATIC HYPERPLASIA IN MEN WITH METABOLIC SYNDROME AND ANDROGEN DEFICIENCY
Tyuzikov I.A., Grekov E.A., Kalinchenko S.Y.
TRANSURETHRAL ELECTROENUCLEATION OF BENIGN PROSTATIC HYPERPLASIA
Martov A.G., Ergakov D.V., Andronov A.S., Baykov N.A.
The results of the 10-year study of efficacy and safety of Serenoa repens extract in patients at risk of progression of benign prostatic hyperplasia
Alyaev Y.G., Vinarov A.Z., Demidko Y.L., Spivak L.G.
Urological problems related to coloproctology. Part 1
Khryanin A.A., Feofilov I.V., Markaryan D.R., Bocharova V.K.
Ejaculatory disorders after surgical treatment of benign prostatic hyperplasia
Rustamov M.N., Galiullin O.F., Vinarov A.Z.
COMBINATION THERAPY IN THE MANAGEMENT OF URINARY DISORDERS AFTER TRANSURETHRAL RESECTION OF THE PROSTATE
Ergakov D.V., Martov A.G.
Conservative management of benign prostatic hyperplasia: are urologists satisfied?
Govorov A.V.
Efficacy of 5a-reductase inhibitors in the treatment of lower urinary tract symptoms in patients with benign prostatic hyperplasia
Nizov A.N.
Treatment of patients with lower urinary tract symptoms in Moscow
Pushkar D.Y., Rasner P.I., Kotenko D.V., Gerasimov A.N., Shabalkin S.A.
Extract of Serenoa repens in the treatment of benign prostatic hyperplasia and lower urinary tract symptoms
Amdii R.E., Al’-Shukri A.S.
AGE-RELATED ANDROGEN DEFICIENCY AND BENIGN PROSTATIC HYPERPLASIA: HOW TO IMPROVE THE REHABILITATION OF PATIENTS AFTER TRANSURETHRAL SURGERY?
Martov A.G., Ergakov D.V.
SILODOSIN IN THE TREATMENT OF PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA - RESULTS OF RUSSIAN MULTICENTER OBSERVATIONAL STUDY
Pushkar D.Y., Bernikov A.N., Sadchenko A.V.
Ejaculatory-protective transurethral resection of the prostate
Martov A.G., Andronov A.S., Dutov S.V., Baykov N.A.
EXPERIENCE OF PERFORMING THE EXTRAURETHRAL TRANSVESICAL ADENOMECTOMY IN PATIENTS WITH BPH
Vasilchenko M.I., Shershnev S.P., Zelenin D.A., Zagarova V.I., Proletarsky A.V.
The use of prostate extract preparations in patients after transurethral resection of prostate for its benign hyperplasia
Pavlov V.N., Kazikhinurov A.A., Kazikhinurov R.A., Sabirzyanov S.S., Saleeva Y.D., Kazikhinurova K.A.
CURRENT APPROACHES TO CONSERVATIVE TREATMENT OF MEN WITH CONCOMITANT BENIGN PROSTATIC HYPERPLASIA AND ERECTILE DYSFUNCTION
Kamalov A.A., Takhirzade A.M.
Our experience of using hexane extract of Serenoa Repens fruit (Permixone) in the treatment of LUTS in clinical practice
Kuzmenko A.V., Gyaurgiev T.A., Kuzmenko G.A.
COMPARATIVE ANALYSIS OF THE EFFECTIVENESS OF EARLY AND DELAYED INITIATION OF COMBINED DRUG THERAPY FOR BPH
Kuzmenko A.V., Kuzmenko V.V., Gyaurgiev T.A.
VITAPROST FORTE IN THE TREAMENT OF PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA: PATHOGENETIC BASICS AND CLINICAL RESULTS
Kuz’min I.V.
A comparative analysis of the effectiveness of serenoa repens and serenoa repens in combination with urtica dioiccus for lower urinary symptoms suggestive of benign prostatic hyperplasia associated with chronic inflammation in prostate tissue
Ibishev K.S., Krainy P.A., Mitusov V.V., Sizyakin D.V., Magomedov G.A.
The effectiveness and safety of Omnik OCAS in patients with lower urinary tract symptoms secondary to benign prostatic hyperplasia in the routine clinical practice in the Russian Federation (prospective multi-center observing program)
Loran O.B., Seregin A.A.
ASSOCIATION OF LOWER URINARY TRACT SYMPTOMS AND TESTOSTERONE DEFICIENCY IN MEN WITH TYPE 2 DIABETES
Kogan M.I., Belousov I.I., Ibishev H.S., Cherniy A.A., Khripun I.A., Vorobyev S.V., Sizaykin D.V.
Treatment of erectile dysfunction following transvesical prostatectomy
Motin P.I., Andrjuhin M.I., Pulbere S.A., Alekseev O.J., Agaev N.K.
EXPERIENCE OF THE USE OF DRUG UROREC: EFFICACY AND SAFETY
Kadiev R.M., Derevyanko T.I.
PHOTOSELECTIVE VAPORIZATION IN TREATMENT OF BENIGN PROSTATIC HYPERPLASIA IN ELDERLY AND SENILE MEN
Morozov A.P., Morozov A.A.
Evaluation of long-term results of the use of entomological drug in the combination therapy of patients with benign prostatic hyperplasia and chronic prostatitis
Kuzmenko A.V., Kuzmenko V.V., Gyaurgiev T.A., Kuzmenko G.A.
A multicenter, randomized, parallel, controlled, prospective, open-label study of the efficiency and safety of bovhyaluronidase azoximer in combination therapy in patients with lower urinary tract symptoms due to benign prostatic hyperplasia
Rasner P.I., Al-Shukri A.S., Shormanov I.S., Tazhetdinov O.K., Maksimova A.V.
INTRAVESICAL PROSTATIC PROTRUSION IN DIAGNOSING INFRAVESICAL OBSTRUCTION IN MEN WITH BENIGN PROSTATIC HYPERPLASIA
Krivoborodov G.G., Efremov N.S., Bolotov A.D.
TRANSABDOMINAL AND TRANSRECTAL ULTRASOUND ASSESSMENT OF INTRAVESICAL PROSTATIC PROTRUSION
Krivoborodov G.G., Efremov N.S., Bolotov A.D.
Therapeutic efficacy and safety of monotherapy Alfuprost® MR 10 mg/day in clinical practice
Novikov A.I., Shpilenya E.S.
The role of obesity in the pathogenesis of benign prostatic hyperplasia
Bratchikov O.I., Tyuzikov I.A., Artishchev S.O., Shumakova E.A.
EFFICIENCY OF PHOSPHODIESTERASE-5 INHIBITORS FOR TREATMENT OF LOWER URINARY TRACT SYMPTOMS IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA AND CONCOMITANT ERECTILE DYSFUNCTION
Kamalov A.A., Nizov A.N.
The choice of individual treatment strategy in geriatric patients with benign prostatic hyperplasia with consideration of indications and contraindications for elective isolated and simultaneous interventions
Leschenko I.G., Bratchikov O.I., Shatokhina I.V., Akimov A.I.
The effects of combination therapy with 5a-reductase inhibitor and a-blocker on the prognosis of BPH
Neimark A.I., Davydov A.V., Aliev R.T.
1 - 100 of 105 Items 1 2 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"